Skip to main content

Advertisement

Log in

The epidemiology, clinical, biochemical, immunological and radiological features of youth onset type 2 diabetes mellitus in the state of Qatar

  • Original Article
  • Published:
Diabetology International Aims and scope Submit manuscript

Abstract

Objectives

To describe the epidemiology, clinical, biochemical, immunological and radiological aspects of youth with type 2 diabetes.

Methods

Patients under 18 year of age with type 2 diabetes were recruited from 2018 to 2020, clinical data collected, autoantibodies (GAD65, IAA, IA2 and ZnT8), insulin, ALT and c-peptide were measured. Hepatic ultrasound was performed for assessment of non-alcoholic fatty liver disease (NAFLD).

Results

104 patients were identified. The incidence in 2020 and prevalence per 100,000 was 2.51 and 23.7, respectively. The age of onset was between 8.5 and 18 years with 74% of the patients being of Qatari nationality. Males were more affected than females (1.5/1). Overweight/obesity was present in 98% of all the patients, a positive family history (either both parents or a single parent) in 71% and maternal gestational diabetes mellitus (GDM) in 60% of patients. More than 90% of the patients had acanthosis nigricans. 5 patients had 1 autoantibody positivity and hepatic ultrasound detected evidence of NAFLD in majority of patients.

Conclusion

Obesity, maternal GDM and family history of diabetes were the key risk factors for the development of type 2 diabetes. Autoantibody positivity may be present in youth type 2 diabetes. As youth type 2 diabetes is associated with early onset microvascular and macrovascular complications, these findings have important social and health budget implications for Qatar. Tackling the burden of maternal GDM and childhood obesity and building programmes for early detection and intervention, are therefore, essential to reduce the risk of future complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

Restrictions apply to the availability of some or all data generated or analysed during this study to preserve patient confidentiality. The corresponding author will on request detail the restrictions and any conditions under which access to some data may be provided.

Abbreviations

GAD65:

Glutamic acid decarboxylase 65

IAA:

Insulin autoantibody

IA2:

Islet antigen-2 auto antibody

ZnT8:

Zinc transporter 8

NAFLD:

Non-alcoholic fatty liver disease

GDM:

Gestational diabetes mellitus

CI:

Confidence interval

TG:

Triglyceride

References

  1. Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014;311(17):1778–86.

    Article  CAS  Google Scholar 

  2. Kahn CR. Banting Lecture: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994;43:1066–84.

    Article  CAS  Google Scholar 

  3. Nesmith JD. Type 2 diabetes mellitus in children and adolescents. Pediatr Rev. 2001;22(5):147–52. https://doi.org/10.1542/pir.22-5-147.

    Article  CAS  PubMed  Google Scholar 

  4. Gungor N, Arslanian S. Pathophysiology of type 2 diabetes mellitus in children and adolescents: treatment implications. Treat Endocrinol. 2002;1:359–71.

    Article  Google Scholar 

  5. Juárez-López C, Klünder-Klünder M, Medina-Bravo P, Madrigal-Azcárate A, Mass-Díaz E, Flores-Huerta S. Insulin resistance and its association with the components of the metabolic syndrome among obese children and adolescents. BMC Public Health. 2010;10:318.

    Article  Google Scholar 

  6. Nahhas MA, Asamoah F, Mullen S, Nwaru BI, Nurmatov U. Epidemiology of overweight and obesity in early childhood in the Gulf Cooperation Council countries: a systematic review and meta-analysis protocol. BMJ Open. 2018;8(6):e019363.

    Article  Google Scholar 

  7. Stančáková A, Laakso M. Genetics of Type 2 diabetes. Endocr Dev. 2016;31:203–20.

    Article  Google Scholar 

  8. O’Beirne SL, Salit J, Rodriguez-Flores JL, Staudt MR, Abi Khalil C, Fakhro KA, et al. Type 2 diabetes Risk Allele Loci in the Qatari Population. PLoS ONE. 2016;11(7):e0156834.

    Article  Google Scholar 

  9. Punnose J, Agarwal MM, Bin-Uthman S. Type 2 diabetes mellitus among children and adolescents in Al-Ain: a case series. East Mediterr Health J. 2005;11:788–97.

    CAS  PubMed  Google Scholar 

  10. Moussa MA, Alsaeid M, Abdella N, Refai TM, Al-Sheikh N, Gomez JE. Prevalence of type 2 diabetes mellitus among Kuwaiti children and adolescents. Med Princ Pract. 2008;17:270–5.

    Article  Google Scholar 

  11. Al-Rubeaan K. National surveillance for type 1, type 2 diabetes and prediabetes among children and adolescents: a population-based study (SAUDI-DM). J Epidemiol Community Health. 2015;69(11):1045–51.

    Article  Google Scholar 

  12. Al-Agha A, Ocheltree A, Shata N. Prevalence of hyperinsulinism, type 2 diabetes mellitus and metabolic syndrome among Saudi overweight and obese pediatric patients. Minerva Pediatr. 2012;64(6):623–31.

    CAS  PubMed  Google Scholar 

  13. Mirbolouk M, Derakhshan A, Charkhchi P, Guity K, Azizi F, Hadaegh F. Incidence and predictors of early adulthood pre-diabetes/type 2 diabetes, among Iranian adolescents: the Tehran Lipid and Glucose Study. Pediatr Diabetes. 2016;17(8):608–16.

    Article  CAS  Google Scholar 

  14. Robert AA, Al Dawish MA, Braham R, Musallam MA, Al Hayek AA, Al Kahtany NH. Type 2 diabetes mellitus in saudi arabia: major challenges and possible solutions. Curr Diabetes Rev. 2017;13:59–64.

    Article  Google Scholar 

  15. Alyafei F, Soliman A, Alkhalaf F, Sabt A, De Sanctis V, Waseef R, et al. Incidence of type 1 and type 2 diabetes, between 2012–2016, among children and adolescents in Qatar. Acta Biomed. 2018;89:7–10.

    PubMed  PubMed Central  Google Scholar 

  16. Al-Kandari H, Al-Abdulrazzaq D, Davidsson L, Sharma P, Al-Tararwa A, Mandani F, et al. Incidence of type 2 diabetes in kuwaiti children and adolescents: results from the childhood-onset diabetes electronic registry (CODeR). Front Endocrinol (Lausanne). 2019;10:836.

    Article  Google Scholar 

  17. Osman HA, Elsadek N, Abdullah MA. Type 2 diabetes in Sudanese children and adolescents. Sudan J Paediatr. 2013;13(2):17–23.

    PubMed  PubMed Central  Google Scholar 

  18. Moussa MA, Alsaeid M, Abdella N, Refai TM, Al-Sheikh N, Gomez JE. Prevalence of type 2 diabetes mellitus among Kuwaiti children and adolescents. Med Princ Pract. 2008;17(4):270–5.

    Article  Google Scholar 

  19. Taheri S, Zaghloul H, Chagoury O, Elhadad S, Ahmed SH, El Khatib N, et al. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol. 2020;8(6):477–89.

    Article  Google Scholar 

  20. Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc. 1998;73(12):1161–6. https://doi.org/10.4065/73.12.1161.

    Article  CAS  PubMed  Google Scholar 

  21. Masuda M, Powell M, Chen S, Beer C, Fichna P, Rees Smith B, et al. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay. Clin Chim Acta. 2000;291(1):53–66. https://doi.org/10.1016/s0009-8981(99)00199-0.

    Article  CAS  PubMed  Google Scholar 

  22. Dabelea D, Pettitt DJ, Hanson RL, Imperatore G, Bennett PH, Knowler WC. Birth weight, type 2 diabetes, and insulin resistance in Pima Indian children and young adults. Diabetes Care. 1999;22:944–50.

    Article  CAS  Google Scholar 

  23. American Diabetes Association. Type 2 diabetes in children and adolescents. Diabetes Care. 2000;23:381–9.

    Article  Google Scholar 

  24. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346:802–10.

    Article  CAS  Google Scholar 

  25. McCance DR, Pettitt DJ, Hanson RL, Jacobsson LT, Knowler WC, Bennett PH. Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? BMJ. 1994;308(6934):942–5.

    Article  CAS  Google Scholar 

  26. Pettitt DJ, Baird HR, Aleck KA, Bennett PH, Knowler WC. Excessive obesity in offspring of Pima Indian women with diabetes during pregnancy. N Engl J Med. 1983;308(5):242–5.

    Article  CAS  Google Scholar 

  27. Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care. 1993;16(1):310–4.

    Article  CAS  Google Scholar 

  28. Hutchins J, Barajas RA, Hale D, Escaname E, Lynch J. Type 2 diabetes in a 5-year-old and single center experience of type 2 diabetes in youth under 10. Pediatr Diabetes. 2017;18(7):674–7.

    Article  CAS  Google Scholar 

  29. Scott CR, Smith JM, Cradock MM, Pihoker C. Characteristics of youth-onset noninsulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus at diagnosis. Pediatrics. 1997;100(1):84–91.

    Article  CAS  Google Scholar 

  30. Rosenbloom A, Joe J, Young R, Winter W. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999;22:345–54.

    Article  CAS  Google Scholar 

  31. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Type 2 diabetes in Asian-Indian urban children. Diabetes Care. 2003;26:1022–5.

    Article  Google Scholar 

  32. Umpaichitra V, Banerji MA, Castells S. Autoantibodies in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2002;15(Suppl. 1):525–30.

    CAS  PubMed  Google Scholar 

  33. Reinehr T, Schober E, Wiegand S, Thon A, Holl RL. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch Dis Child. 2006;91:473–7.

    Article  CAS  Google Scholar 

  34. Klingensmith GJ, Pyle L, Arslanian S, Copeland KC, Cuttler L, Kaufman F, et al. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care. 2010;33(9):1970–5.

    Article  CAS  Google Scholar 

  35. Alyafei F, Soliman A, Alkhalaf F, Sabt A, De Sanctis V, Elsayed N, et al. Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar. Acta Biomed. 2018;89(S5):32–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Hathout EH, Thomas W, El-Shahawy M, Nahab F, Mace JW. Diabetic autoimmune markers in children and adolescents with type 2 diabetes. Pediatrics. 2001;107(6):E102.

    Article  CAS  Google Scholar 

  37. Hecht L, Weiss R. Nonalcoholic fatty liver disease and type 2 diabetes in obese children. Curr Diab Rep. 2014;14(1):448.

    Article  Google Scholar 

  38. Newton KP, Hou J, Crimmins NA, Lavine JE, Barlow SE, Xanthakos SA, et al. Prevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease. JAMA Pediatr. 2016;170(10):e161971.

    Article  Google Scholar 

  39. Williamson RM, Perry E, Glancy S, Marshall I, Gray C, Nee LD, et al. The use of ultrasound to diagnose hepatic steatosis in type 2 diabetes: intra- and interobserver variability and comparison with magnetic resonance spectroscopy. Clin Radiol. 2011;66(5):434–9.

    Article  CAS  Google Scholar 

  40. Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R, Leite-Moreira A. The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. Hepatol Int. 2010;4(4):659–72.

    Article  Google Scholar 

  41. Krakoff J, Lindsay RS, Looker HC, Nelson RG, Hanson RL, Knowler WC. Incidence of retinopathy and nephropathy in youth onset compared with adult-onset type 2 diabetes. Diabetes Care. 2003;26:76–81.

    Article  Google Scholar 

Download references

Funding

This research was supported by the Qatar National Research Fund (QNRF-NPRP 10–6100017-AXX) awarded to Professor Khalid Hussain.

Author information

Authors and Affiliations

Authors

Contributions

SMA, BH, KH drafted the manuscript, SMA and BH recruited the patients, collected, analysed and interpreted data, KH designed the study, obtained funding, reviewed and edited the manuscript SS, AE, AK, NH, HA, TRA, HD, MA, MA, AS, FA, GP collected patient information, reviewed the manuscript. The guarantor for this project is Professor Khalid Hussain and takes responsibility for the integrity of the data presented.

Corresponding author

Correspondence to Khalid Hussain.

Ethics declarations

Conflict of interest

All authors have no conflicts of interest to declare.

Human and animal rights

This study was approved by the Institutional Review Board (IRB) for the protection of human subjects in Sidra Medicine, Qatar. Approval number 1702007592, approved on 03–10-2017. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and/or with the Helsinki Declaration of 1964 and later versions.

Informed consent

Informed consent or substitute for it was obtained from all patients for being included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmed, S.M., Haris, B., Saraswathi, S. et al. The epidemiology, clinical, biochemical, immunological and radiological features of youth onset type 2 diabetes mellitus in the state of Qatar. Diabetol Int 13, 381–386 (2022). https://doi.org/10.1007/s13340-021-00548-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13340-021-00548-9

Keywords

Navigation